In the search for ways to effectively combat age-related human disease, the enzyme sirtuin 6 (Sirt6) has recently become a focus of biochemical research. A targeted activation of Sirt6 could prevent or mitigate such diseases, for example some types of cancer. In a paper for the journal "Nat ... more
Prof. Dr. Stephan Schwarzinger
Universität Bayreuth, Forschungszentrum für Bio-Makromoleküle (FZ BIOmac)
studied technical chemistry in combination with business administration at the University of Linz, completing his doctorate there in 1999. This was followed by a period of post-doc work at The Scripps Research Institute,
La Jolla, CA, before joining the Department of Biopolymers at the University of Bayreuth in 2000, where he completed his habilitation in 2006 in biophysical chemistry. In 2008 he served as interim head of the Department of Biochemistry at the University of Bayreuth. A member of the BIOmac research centre since 2010, he has been adjunct professor there since 2013. He is also CEO of ALNuMed GmbH. His research interests include NMR methods for the characterisation of flexible proteins, NMR-based food analytics, and the application of combined analysis methods.